14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 MGNX stock ended at $14.66. This is 8.66% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 14.66% from a day low at $13.71 to a day high of $15.72.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
Feb 10, 2016 $16.36 $17.38 $15.83 $16.06 207 400
Feb 09, 2016 $15.87 $16.83 $15.52 $16.21 236 300
Feb 08, 2016 $17.91 $18.23 $15.70 $16.21 400 800
Feb 05, 2016 $18.97 $19.65 $17.97 $18.23 331 300
Feb 04, 2016 $18.50 $20.44 $18.19 $19.18 207 600
Feb 03, 2016 $19.85 $19.90 $17.62 $18.53 302 600
Feb 02, 2016 $20.34 $20.49 $19.48 $19.70 202 300
Feb 01, 2016 $20.03 $21.02 $19.24 $20.64 216 600
Jan 29, 2016 $19.49 $20.35 $18.97 $20.13 275 800
Jan 28, 2016 $20.74 $22.64 $19.37 $19.49 271 500
Jan 27, 2016 $22.15 $22.33 $20.45 $20.54 246 100
Jan 26, 2016 $22.34 $22.44 $21.13 $22.15 182 000
Jan 25, 2016 $22.16 $23.62 $21.66 $22.29 281 600
Jan 22, 2016 $21.99 $22.41 $21.12 $22.31 246 300
Jan 21, 2016 $22.11 $22.44 $21.04 $21.23 241 500
Jan 20, 2016 $21.49 $22.79 $20.47 $21.98 326 700
Jan 19, 2016 $23.01 $23.01 $21.11 $21.88 275 200
Jan 15, 2016 $22.58 $23.76 $21.84 $22.44 257 100
Jan 14, 2016 $22.73 $23.96 $21.42 $23.79 323 200
Jan 13, 2016 $24.81 $25.03 $22.18 $22.54 367 300
Jan 12, 2016 $23.78 $25.34 $23.51 $24.85 375 900
Jan 11, 2016 $25.02 $25.07 $22.84 $23.17 292 700
Jan 08, 2016 $26.19 $26.95 $24.75 $24.82 215 500
Jan 07, 2016 $26.82 $27.24 $25.81 $26.07 240 700
Jan 06, 2016 $27.87 $28.18 $26.61 $27.62 250 300
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT